Regenerative therapy for central nervous system trauma

Regenerative Medicine: From Protocol to Patient

Volumn , Issue , 2011, Pages 605-625

  Jain, Kewal K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856221431     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-9075-1_25     Document Type: Chapter

References (54)

1. Ang BT, Xu G, Xiao ZC. Therapeutic vaccination for central nervous system repair. Clin Exp Pharmacol Physiol 2006;33:541-5.
2. Atalay B, Bavbek M, Ozen O, et al. Nogo-A inhibitory peptide (NEP1-40) increases pan-cadherin expression following mild cortical contusion injury in rats. Turk Neurosurg 2008;18:356-65.
3. Bani-Yaghoub M, Tremblay RG, Ajji A, et al. Neuroregenerative strategies in the brain: emerging significance of bone morphogenetic protein 7 (BMP7). Biochem Cell Biol 2008;86:361-9.
4. Baptiste DC, Austin JW, Zhao W, Nahirny A, Sugita S, Fehlings MG. Systemic polyethylene glycol promotes neurological recovery and tissue sparing in rats after cervical spinal cord injury. J Neuropathol Exp Neurol 2009;68:661-76.
5. Bonnici B, Kapfhammer JP. Modulators of signal transduction pathways can promote axonal regeneration in entorhino-hippocampal slice cultures. Eur J Pharmacol 2009;612:35-40.
6. Buchli AD, Rouiller E, Mueller R, Dietz V, Schwab ME. Repair of the injured spinal cord. A joint approach of basic and clinical research. Neurodegener Dis 2007;4:51-6.
7. Buss A, Pech K, Kakulas BA, et al. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury. BMC Neurology 2009;9:32 doi:10.1186/1471-2377-9-32.
8. Calza L, Giuliani A, Fernandez M, et al. Neural stem cells and cholinergic neurons: Regulation by immunolesion and treatment with mitogens, retinoic acid, and nerve growth factor. Proc Natl Acad Sci USA 2003;100:7325-30.
9. Cardenas DD, Ditunno J, Graziani V, et al. Phase 2 trial of sustained-release fampridine in chronic spinal cord injury. Spinal Cord 2007;45:158-68.
10. Cotman CW, Scheff SW. Compensatory synapse growth in aged animals after neuronal death. Mech Ageing Dev 1979;9:103-17.
11. Courtine G, Gerasimenko Y, van den Brand R, et al. Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat Neurosci 2009;12:1333-42.
12. del Rio-Hortega P. Microglia. In: Penfield W, editor. Cytology and cellular pathology of the nervous system. Vol 2. New York: Paul Hoeber, 1932:481-534.
13. Di Giovanni S, De Biase A, Yakovlev A, et al. In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury. J Biol Chem 2005;280:2084-91.
14. Ellis-Behnke RG, Liang YX, You SW, et al. Nano neuro knitting: Peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA 2006;103:5054-9.
15. Filbin MT. PirB, a second receptor for the myelin inhibitors of axonal regeneration Nogo66, MAG, and OMgp: Implications for regeneration in vivo. Neuron 2008;60:740-2.
16. Goldstein K. Uber die plastitat des organismus auf grund von erfahrungen am nervenkranken menschen. In: Bethe A, editor. Handbuch der normalen und pathologischen physiologie. Berlin: Springer-Verlag, 1931:1131-74.
17. Guo J, Leung KK, Su H, et al. Self-assembling peptide nanfiber scaffold promotes the reconstruction of acutely injured brain. Nanomedicine 2009;5:345-51.
18. Gurgo RD, Bedi KS, Nurcombe V. Current concepts in central nervous system regeneration. J Clin Neurosci 2002;9:613-7.
19. Hamid S, Hayek R. Role of electrical stimulation for rehabilitation and regeneration after spinal cord injury: An overview. Eur Spine J 2008;17:1256-69.
20. Harting MT, Baumgartner JE, Worth LL, et al. Cell therapies for traumatic brain injury. Neurosurg Focus 2008;24:E18.
21. Ibarra A, Martiñón S. Pharmacological approaches to induce neuroregeneration in spinal cord injury: An overview. Curr Drug Discov Technol 2009;6:82-90.
22. Jain KK. Cell therapy for CNS trauma. Mol Biotechnol 2009;42:367-76.
23. Jain KK. The Handbook of Nanomedicine. Totowa, NJ: Springer-Humana, 2008.
24. Kaneko S, Iwanami A, Nakamura M, et al.. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 2006;2:380-9.
25. Klapka N, Muller HW. Collagen matrix in spinal cord injury. J Neurotrauma 2006;23:422-35.
26. Kozorovitskiy Y, Gross CG, Kopil C, et al. Experience induces structural and biochemical changes in the adult primate brain. Proc Natl Acad Sci USA 2005;102:17478-82.
27. Kubo T, Yamaguchi A, Iwata N, Yamashita T. The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Ther Clin Risk Manag 2008;4:605-15.
28. Laverty PH, Leskovar A, Breur GT, et al. A preliminary study of intravenous surfactants in paraplegic dogs: Polymer therapy in canine clinical SCI. J Neurotrauma 2004;21:1767-77.
29. Lee H, McKeon RJ, Bellamkonda RV. Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. PNAS 2009; doi:10.1073-pnas.0905437106.
30. Luo J, Shi R. Polyethylene glycol inhibits apoptotic cell death following traumatic spinal cord injury. Brain Res 2007;1155:10-6.
31. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 2007;8:755-65.
32. Maegele M, Schaefer U. Stem cell-based cellular replacement strategies following traumatic brain injury (TBI). Minim Invasive Ther Allied Technol 2008;17:119-31.
33. Mitchell SW. Injuries of nerves. Philadelphia: JB Lippincott & Co, 1872.
34. Neumann S, Woolf CJ. Regeneration of dorsal column fibers into and beyond the lesion site following spinal cord injury. Neuron 2000;23:83-91.
35. Nilsson M, Pekny M. Enriched environment and astrocytes in central nervous system regeneration. J Rehabil Med 2007;39:345-52.
36. Norman LL, Stroka K, Aranda-Espinoza H. Guiding Axons in the Central Nervous System: A Tissue Engineering Approach. Tissue Eng Part B: Rev 2009;15:291-305.
37. Orive G, Anitua E, Pedraz JL, Emerich DF. Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci 2009;10:682-92.
38. Pal R, Venkataraman NK, Jan M, et al. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: A pilot clinical study. Cytotherapy 2009;11:897-911.
39. Park HC, Shim YS, Ha Y, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 2005;11:913-22.
40. Ramon y Cajal S. Degeneration and regeneration in the nervous system. May RM, translator. New York: Haffner, 1959.
41. Ronsyn MW, Berneman ZN, Van Tendeloo VF, Jorens PG, Ponsaerts P. Can cell therapy heal a spinal cord injury? Spinal Cord 2008;46:532-9.
42. Shen F, Wen L, Yang X, Liu W. The potential application of gene therapy in the treatment of traumatic brain injury. Neurosurg Rev 2007;30:291-8.
43. Someya Y, Koda M, Dezawa M, et al. Reduction of cystic cavity, promotion of axonal regeneration and sparing, and functional recovery with transplanted bone marrow stromal cell-derived Schwann cells after contusion injury to the adult rat spinal cord. J Neurosurg Spine 2008;9:600-10.
44. Stern M, Bicker G. Nitric oxide regulates axonal regeneration in an insect embryonic CNS. Dev Neurobiol 2008;68:295-308.
45. Tabesh H, Amoabediny G, Nik NS, et al. The role of biodegradable engineered scaffolds seeded with Schwann cells for spinal cord regeneration. Neurochem Int 2009;54:73-83.
46. Tate CC, Shear DA, Tate MC, Archer DR, Stein DG, LaPlaca MC. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J Tissue Eng Regen Med 2009;3:208-17.
47. Thompson WG. Successful brain grafting. NY Med J 1890;51:701.
48. Walmsley AR, Mir AK. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Curr Pharm Des 2007;13:2470-84.
49. Xie F, Zheng B. White matter inhibitors in CNS axon regeneration failure. Exp Neurol 2008;209:302-12.
50. Xu XM, Onifer SM. Transplantation-mediated strategies to promote axonal regeneration following spinal cord injury. Respir Physiol Neurobiol 2009;169:171-82.
51. Yang XF, Zheng XS, Liu WG, Feng JF. Bcl-2 gene therapy for apoptosis following traumatic brain injury. Chin J Traumatol 2006;9:276-81.
52. Yaron A, Zheng B. Navigating their way to the clinic: emerging roles for axon guidance molecules in neurological disorders and injury. Dev Neurobiol 2007:67-121631.
53. York GK, Steinberg DA. Hughling Jackson's theory of cerebral localization. J Hist Neurosci 1994;3:153-68.
54. Yu P, Huang L, Zou J, et al. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats. Neurobiol Dis 2008;32:535-42.